<DOC>
	<DOCNO>NCT01406080</DOCNO>
	<brief_summary>The purpose study : 1 . Evaluate efficacy Adapalene gel 0.3 % compare Tretinoin Emollient cream 0.05 % , reduce sign cutaneous photoageing , measure trough photonumeric scale evaluation , investigator evaluation global response treatment subject 's evaluation improvement . 2 . Evaluate safety tolerability Adapalene Gel 0.3 % , compare Tretinoin Emollient cream 0.05 % 24 week treatment . The study clinical hypothesis Adapalene Gel 0.3 % effective Tretinoin Emollient cream 0.05 % treatment cutaneous photoaging .</brief_summary>
	<brief_title>A Comparative Study Adapalene Gel,0.3 % Versus Tretinoin Emollient Cream , 0.05 % Treatment Photoaging</brief_title>
	<detailed_description />
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Emollients</mesh_term>
	<criteria>Patients present least score periorbital frontal wrinkle melanosis maximum `` Severe '' score criterion consider evaluate cutaneous photoaging extension , base table assess Cutaneous Photoaging Extent ; Male female patient age least 35 year maximum 55 year , skin phototype I IV , accord T.B . Fitzpatrick 's scale ; Individuals mild moderate cutaneous photoaging , i.e. , score 26 overall assessment cutaneous photoaging , base Griffiths scale ; If female , individual get pregnant ( define postmenopausal lack menstrual bleed one year undergone bilateral tubal ligation , hysterectomy bilateral oophorectomy ) , childbearing age , patient underwent urine pregnancy test negative result . Patients use appropriate contraceptive method . In case oral contraceptive , use must start least one month study 12 month case pill contain cyproterone . Patients maintain contraceptive study 1 additional month completion ; For subject treatment concomitant medical condition , type dose must stable least three month prior study entry ( least one year , case hormone replacement therapy ) change study . These drug include exclude drug cite exclusion criterion ; Individuals able avoid prolong sun exposure , especially face study period willing use proper technique avoid sun , include use sunscreen provide study ; Individuals able follow study instruction willing complete require visit ; Individuals sign informed consent form study procedure ; Patients participate another clinical trial le 30 day ; Pregnant woman , nurse mother woman attempt conceive ; Female patient start hormone replacement therapy less one year enter study ; Individuals condition situation , opinion investigator , may put objective study risk , confound result even interfere individual participation . These include , limited : 1 . Individuals facial skin disorder dermatosis ( scar , inflammatory acne , etc . ) interfere clinical evaluation ; 2 . Patients history treatment photoaging use ablative laser technology ( carbon dioxide Erbium : YAG ) / nonablative ( Nd : YAG , Fractionated Erbium Glass , Diode , Infrared Light , Intense Pulsed Light , Radiofrequency , Pulsed Dye Laser ) , dermabrasion , medium deep chemical peel face ; 3 . Individuals diagnose skin cancer ( squamous cell carcinoma , melanoma ) last 3 month prior study entry ; 4 . Individuals willing refrain cosmetic procedure study period ( e.g . type chemical peeling , microdermabrasion , etc . ) ; 5 . Individuals significant medical history , concomitant disease condition investigator believe participation study propitious ; Patients know sensitivity retinoids component study product ; Patients diagnosis history keloid ; Patients without minimum washout period follow treatment : 1 . 2 week topical alpha hydroxy acid , glycolic acid , salicylic acid , lactic acid , betahydroxy acid face . 2 . 2 week topical product contain vitamin A , ascorbic acid , vitamin E face . 3 . 2 week topical corticosteroid . 4 . 4 week systemic corticosteroid . 5 . 3 month topical retinoids . 6 . 1 year oral retinoids . Patients underwent superficial chemical peeling , microdermabrasion exfoliation face last 3 month ; Patients apply botulinum toxin soft tissue filler facial rejuvenation last 6 month agree use product study ; Patients selfidentified `` sensitive skin '' ; Patients willing able attend study visit ;</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Photoaging</keyword>
	<keyword>Photodamage</keyword>
	<keyword>Adapalene</keyword>
	<keyword>Differin</keyword>
</DOC>